• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 大流行对膀胱癌患者的影响:一项多中心真实世界研究。

Impact of the COVID-19 pandemic on bladder cancer patients: a multicenter real-world study.

机构信息

Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

出版信息

J Int Med Res. 2023 Oct;51(10):3000605231204465. doi: 10.1177/03000605231204465.

DOI:10.1177/03000605231204465
PMID:37873755
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10594970/
Abstract

OBJECTIVE

Hospital management and medical treatment changed during the coronavirus disease 2019 (COVID-19) pandemic. This study investigated the impact of the COVID-19 pandemic on patients with bladder cancer.

METHODS

In this multicenter retrospective study, we collected information from the electronic medical records of outpatients who underwent cystoscopy and inpatients with confirmed bladder cancer in three hospitals in Nanjing (two province-level and one county-level hospitals) in 2019 and 2020. Patients' home addresses, treatment methods, length of stay, and pathology were compared between the periods.

RESULTS

In total, 4048 outpatients and 1242 inpatients were included. The average number of cystoscopies decreased significantly during the lockdown. In province-level hospitals, the number of cystoscopies increased gradually as the pandemic was brought under control but remained lower than that in 2019, whereas the number grew in 2020 in county-level hospitals. The rates of recurrence and radical cystectomy were higher in 2020 than in 2019. No significant difference in the pathological grade was observed. More patients who underwent radical cystectomy were diagnosed with muscle-invasive bladder cancer during the 2020 lockdown.

CONCLUSION

The pandemic severely affected patients with bladder cancer, mainly in their choice of institution and treatment.

摘要

目的

2019 年冠状病毒病(COVID-19)大流行期间,医院管理和医疗发生了变化。本研究调查了 COVID-19 大流行对膀胱癌患者的影响。

方法

在这项多中心回顾性研究中,我们收集了 2019 年和 2020 年在南京的三家医院(两家省级医院和一家县级医院)接受膀胱镜检查的门诊患者和确诊膀胱癌的住院患者的电子病历信息。比较了两个时期患者的家庭住址、治疗方法、住院时间和病理。

结果

共纳入 4048 例门诊患者和 1242 例住院患者。在封锁期间,膀胱镜检查的数量明显减少。在省级医院,随着疫情得到控制,膀胱镜检查的数量逐渐增加,但仍低于 2019 年的数量,而县级医院的数量在 2020 年增加。2020 年的复发率和根治性膀胱切除术率高于 2019 年。病理分级无显著差异。在 2020 年的封锁期间,更多接受根治性膀胱切除术的患者被诊断为肌层浸润性膀胱癌。

结论

大流行严重影响了膀胱癌患者,主要影响了他们选择的医疗机构和治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1753/10594970/89ced2abb8a4/10.1177_03000605231204465-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1753/10594970/020a864549a7/10.1177_03000605231204465-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1753/10594970/db43a7539a3e/10.1177_03000605231204465-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1753/10594970/89ced2abb8a4/10.1177_03000605231204465-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1753/10594970/020a864549a7/10.1177_03000605231204465-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1753/10594970/db43a7539a3e/10.1177_03000605231204465-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1753/10594970/89ced2abb8a4/10.1177_03000605231204465-fig3.jpg

相似文献

1
Impact of the COVID-19 pandemic on bladder cancer patients: a multicenter real-world study.COVID-19 大流行对膀胱癌患者的影响:一项多中心真实世界研究。
J Int Med Res. 2023 Oct;51(10):3000605231204465. doi: 10.1177/03000605231204465.
2
The Impact of Covid-19 Pandemic on Genitourinary Cancers Stage and Grade.Covid-19 大流行对泌尿生殖系统癌症分期和分级的影响。
Clin Genitourin Cancer. 2023 Feb;21(1):84-90. doi: 10.1016/j.clgc.2022.11.016. Epub 2022 Nov 24.
3
Clinical impact of the suspension of the ERAS protocol on patients undergoing radical cystectomy during the COVID-19 pandemic.在 COVID-19 大流行期间,接受根治性膀胱切除术的患者中,加速康复外科(ERAS)方案暂停的临床影响。
Actas Urol Esp (Engl Ed). 2023 Jul-Aug;47(6):369-375. doi: 10.1016/j.acuroe.2023.01.006. Epub 2023 Feb 24.
4
A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire.约克郡根治性膀胱切除术和根治性放疗治疗浸润性膀胱癌后的发病率、死亡率及长期生存率研究。
Eur Urol. 2003 Mar;43(3):246-57. doi: 10.1016/s0302-2838(02)00581-x.
5
Surviving the Storm: Challenges of Bladder Cancer Care During the COVID-19 Pandemic.安然度过风暴:COVID-19 大流行期间膀胱癌护理的挑战。
Clin Genitourin Cancer. 2024 Oct;22(5):102129. doi: 10.1016/j.clgc.2024.102129. Epub 2024 May 29.
6
Bladder sparing surgery in high-grade bladder cancer.高级别膀胱癌的膀胱保留手术。
Exp Oncol. 2019 Jun;41(2):160-165. doi: 10.32471/exp-oncology.2312-8852.vol-41-no-2.13207.
7
Robotic radical cystectomy for bladder cancer: surgical and pathological outcomes in 100 consecutive cases.机器人根治性膀胱切除术治疗膀胱癌:100 例连续病例的手术和病理结果。
J Urol. 2010 Feb;183(2):510-4. doi: 10.1016/j.juro.2009.10.027. Epub 2009 Dec 14.
8
Management of high-risk non-muscle invasive bladder cancer.高危非肌层浸润性膀胱癌的管理
Minerva Urol Nefrol. 2012 Dec;64(4):255-60.
9
Upper urinary tract recurrence following radical cystectomy for bladder cancer.膀胱癌根治性膀胱切除术后上尿路复发
Int J Urol. 2007 Jun;14(6):496-9. doi: 10.1111/j.1442-2042.2007.01776.x.
10
Robotic versus open radical cystectomy for bladder cancer in adults.成人膀胱癌的机器人辅助与开放性根治性膀胱切除术
Cochrane Database Syst Rev. 2019 Apr 24;4(4):CD011903. doi: 10.1002/14651858.CD011903.pub2.

本文引用的文献

1
Gender, Bladder Cancer Healthcare and Burden of COVID-19.性别、膀胱癌医疗保健和 COVID-19 负担。
Cancer Invest. 2023 Jan;41(1):58-69. doi: 10.1080/07357907.2022.2140351. Epub 2022 Nov 2.
2
Amide Proton Transfer-weighted MRI in Predicting Histologic Grade of Bladder Cancer.酰胺质子转移加权磁共振成像预测膀胱癌组织学分级。
Radiology. 2022 Oct;305(1):127-134. doi: 10.1148/radiol.211804. Epub 2022 Jun 28.
3
Impact of COVID-19 on endourology surgical practice in Saudi Arabia: A national multicenter study.新型冠状病毒肺炎对沙特阿拉伯腔内泌尿外科手术实践的影响:一项全国多中心研究。
Asian J Urol. 2021 Oct;8(4):416-423. doi: 10.1016/j.ajur.2021.03.006. Epub 2021 Mar 26.
4
Effect of Coronavirus Disease 2019 on Patients with Bladder Cancer in China.2019年冠状病毒病对中国膀胱癌患者的影响。
Urol Int. 2021;105(7-8):726-728. doi: 10.1159/000512895. Epub 2021 Feb 24.
5
Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.新冠疫情对澳大利亚、加拿大和荷兰基于粪便免疫化学试验的结直肠癌筛查项目的影响:一项比较建模研究。
Lancet Gastroenterol Hepatol. 2021 Apr;6(4):304-314. doi: 10.1016/S2468-1253(21)00003-0. Epub 2021 Feb 3.
6
The Impact of the COVID-19 Pandemic on Barrett's Esophagus and Esophagogastric Cancer.新冠疫情对巴雷特食管和食管胃癌的影响
Gastroenterology. 2021 May;160(6):2169-2171.e1. doi: 10.1053/j.gastro.2021.01.208. Epub 2021 Jan 26.
7
Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study.COVID-19 大流行对英格兰结直肠癌检测和管理的影响:一项基于人群的研究。
Lancet Gastroenterol Hepatol. 2021 Mar;6(3):199-208. doi: 10.1016/S2468-1253(21)00005-4. Epub 2021 Jan 15.
8
Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era.用于减轻 COVID-19 时代膀胱癌诊断延误的尿液生物标志物。
Nat Rev Urol. 2021 Apr;18(4):185-187. doi: 10.1038/s41585-020-00419-z.
9
Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes.经尿道膀胱肿瘤切除术治疗非肌肉浸润性膀胱癌后延迟卡介苗免疫治疗的起始时间与不良生存结局相关。
World J Urol. 2021 Jul;39(7):2545-2552. doi: 10.1007/s00345-020-03522-3. Epub 2020 Nov 23.
10
Weathering the Storm: Managing Older Adults With Breast Cancer Amid COVID-19 and Beyond.《安然度过风暴:在 COVID-19 及之后时期管理老年乳腺癌患者》。
J Natl Cancer Inst. 2021 Apr 6;113(4):355-359. doi: 10.1093/jnci/djaa079.